Perbedaan Diagnos Laboratorium Utama Tbk. dan Phapros Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Phapros Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 211,68 M, volume 24 jam 116,4 rb). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. lebih besar dari sisi kapitalisasi pasar, dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 116,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | PEHA | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 211,68 M |
Volume | 963,6 rb | 116,4 rb |
Lot | 9,64 rb | 1,16 rb |
Perputaran | 217,67 jt | 29,27 jt |
Harga Rata-rata | 225,89 | 251,47 |
Nilai Transaksi | 217,67 jt | 29,27 jt |
Harga Ekuilibrium Indikatif | 226 | 256 |
Volume Ekuilibrium Indikatif | 1 rb | 20 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Selengkapnya di halaman PEHA →